Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Corcept Therapeutics (CORT)

Corcept Therapeutics (CORT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,422,426
  • Shares Outstanding, K 116,631
  • Annual Sales, $ 353,870 K
  • Annual Income, $ 106,010 K
  • 60-Month Beta 0.72
  • Price/Sales 6.69
  • Price/Cash Flow 21.52
  • Price/Book 4.63
Trade CORT with:

Options Overview

Details
  • Implied Volatility 33.28%
  • Historical Volatility 25.61%
  • IV Percentile 0%
  • IV Rank 0.02%
  • IV High 208.16% on 11/12/20
  • IV Low 33.25% on 06/09/21
  • Put/Call Vol Ratio 0.21
  • Today's Volume 17
  • Volume Avg (30-Day) 186
  • Put/Call OI Ratio 1.04
  • Today's Open Interest 8,811
  • Open Int (30-Day) 10,569

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.21
  • Number of Estimates 3
  • High Estimate 0.23
  • Low Estimate 0.19
  • Prior Year 0.17
  • Growth Rate Est. (year over year) +23.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.63 +5.81%
on 07/28/21
22.58 -8.02%
on 07/01/21
-1.23 (-5.59%)
since 06/30/21
3-Month
19.48 +6.62%
on 05/11/21
23.49 -11.59%
on 06/16/21
-2.02 (-8.86%)
since 04/30/21
52-Week
12.20 +70.25%
on 08/27/20
31.18 -33.39%
on 02/09/21
+4.69 (+29.17%)
since 07/30/20

Most Recent Stories

More News
Corcept's (CORT) Q2 Earnings Beat Estimates, Revenues Rise Y/Y

Corcept (CORT) beats on both earnings and revenues in the second quarter of 2021. The company maintains the revenue guidance for 2021.

BMY : 67.87 (-0.41%)
PFE : 42.81 (+0.05%)
MRK : 76.87 (-0.08%)
CORT : 20.77 (+2.37%)
Corcept Therapeutics (CORT) Q2 Earnings and Revenues Surpass Estimates

Corcept (CORT) delivered earnings and revenue surprises of 50.00% and 6.72%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

CORT : 20.77 (+2.37%)
Corcept: Q2 Earnings Snapshot

MENLO PARK, Calif. (AP) _ Corcept Therapeutics Inc. (CORT) on Thursday reported second-quarter profit of $26.5 million.

CORT : 20.77 (+2.37%)
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and neuropsychiatric disorders by modulating...

CORT : 20.77 (+2.37%)
Dr. Reddy's (RDY) Q1 Earnings Decline Y/Y, Sales Increase

Dr. Reddy's (RDY) earnings decline while sales grow year over year in first-quarter fiscal 2022.

RDY : 62.55 (-1.17%)
RGEN : 245.70 (+1.95%)
CORT : 20.77 (+2.37%)
NBRV : 1.1000 (-0.90%)
CORT or ZTS: Which Is the Better Value Stock Right Now?

CORT vs. ZTS: Which Stock Is the Better Value Option?

CORT : 20.77 (+2.37%)
ZTS : 202.70 (-0.70%)
Corcept Therapeutics To Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call

Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter financial results and provide a corporate update on July 29, 2021. The company will also host a conference...

CORT : 20.77 (+2.37%)
Aldeyra's (ALDX) ADX-2191 Gets Orphan Drug Tag for Rare Cancer

The FDA grants an Orphan Drug designation to Aldeyra's (ALDX) ADX-2191 for the treatment of primary vitreoretinal lymphoma.

CORT : 20.77 (+2.37%)
CANF : 2.00 (-4.31%)
ALDX : 8.90 (-1.33%)
FHTX : 9.07 (-3.51%)
Lilly's (LLY) Protomer Acquisition to Expand Diabetes Pipeline

Lilly (LLY), which holds a 14% stake in private biotech company Protomer, acquires the remaining interest in it. The acquisition is set to expand Lilly's diabetes pipeline.

RHHBY : 48.2600 (+1.05%)
LLY : 243.50 (-0.75%)
CORT : 20.77 (+2.37%)
CTLT : 119.81 (+0.41%)
Catalyst (CPRX) Thrives on Firdapse But Overdependence Concerns

Catalyst's (CPRX) Firdapse is approved for treating Lambert-Eaton myasthenic syndrome. The drug has seen solid uptake since its launch. Sole dependence on Firdapse for growth remains a concern.

CORT : 20.77 (+2.37%)
CPRX : 5.84 (+0.17%)
CANF : 2.00 (-4.31%)
CTLT : 119.81 (+0.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Corcept Therapeutics Incorporated is a pharmaceutical company. It is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The company focuses on disorders that are associated with a steroid hormone called cortisol....

See More

Key Turning Points

3rd Resistance Point 22.91
2nd Resistance Point 22.28
1st Resistance Point 21.52
Last Price 20.77
1st Support Level 20.13
2nd Support Level 19.50
3rd Support Level 18.74

See More

52-Week High 31.18
Fibonacci 61.8% 23.93
Fibonacci 50% 21.69
Last Price 20.77
Fibonacci 38.2% 19.45
52-Week Low 12.20

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar